The Asia Pacific Newborn Screening Market would witness market growth of 7.2% CAGR during the forecast period (2022-2028).
Newborn screening is a public health initiative aimed at identifying infants with treatable illnesses before they manifest clinically or cause irreparable damage. The first disorder to be targeted for the newborn screening was phenylketonuria (PKU), which was adopted in a small number of hospitals before fast spreading throughout the United States and the rest of the country. During the first two years after newborn screening for PKU was achieved, through investigation other disorders that infants could be diagnosed with and treated (39 infants were diagnosed and treated without false negatives); a gradual development bacterial inhibition assay was used to identify classic galactosemia and maple syrup urinary illness.
Since the emergence of PKU screening in the 1960s, newborn screening has become more widespread, albeit it varies widely by country. In 2011, the US screened for 54 disorders, Germany for 12, the UK for two, while France and Hong Kong only screened for one. The conditions included in newborn screening vary greatly across the world, depending on regulatory obligations for screening programs, the prevalence of certain diseases in inhabitants, government pressure, and the access to resources both for testing and obey of recognized patients.
India has an estimated 26 million babies per year. According to the 2011 Census, 13% of the population is between the ages of 0 and 6. Child health programs at the National Health Mission (NHM) focus on promoting child survival as well as addressing factors associated with infant and under-five mortality rates. It is impossible to handle the child's survival in isolation since it is closely tied to the mother's health, which is further influenced by her development as a teenager. India has made headway in reducing newborn mortality, with its share of the newborn mortality load falling from one-third in 1990 to less than a quarter of all newborn fatalities now. In India, there are roughly one million fewer neonatal fatalities and 10,000 fewer maternal deaths per month in 2017 than in 2000. This is due to an increase in the number of women giving birth in hospitals.
The China market dominated the Asia Pacific Newborn Screening Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $128.8 Million by 2028. The Japan market is poised to grow at a CAGR of 6.5% during (2022 - 2028). Additionally, The India market would witness a CAGR of 7.8% during (2022 - 2028).
Based on Product Type, the market is segmented into Consumables and Instrument. Based on Test Type, the market is segmented into Blood Test, Hearing Screening Test, and Heart screening. Based on End User, the market is segmented into Hospitals and Clinical Laboratories. Based on Technology, the market is segmented into Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays & Enzymatic Assays, Hearing Screen Technology, Pulse Oximetry Screening Technology, Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Newborn Screening Market is Projected to reach USD 1.6 Billion by 2028, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Natus Medical Incorporated, Masimo Corporation, Waters Corporation, PerkinElmer, Inc., AB Sciex LLC (Danaher Corporation), Medtronic PLC (Covidien plc), Trivitron Healthcare Pvt. Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
By Test Type
- Blood Test
- Hearing Screening Test
- Heart screening
By End User
- Hospitals
- Clinical Laboratories
By Technology
- Tandem Mass Spectrometry (TMS)
- Molecular Assays
- Immunoassays & Enzymatic Assays
- Hearing Screen Technology
- Pulse Oximetry Screening Technology
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- F. Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- Natus Medical Incorporated
- Masimo Corporation
- Waters Corporation
- PerkinElmer, Inc.
- AB Sciex LLC (Danaher Corporation)
- Medtronic PLC (Covidien plc)
- Trivitron Healthcare Pvt. Ltd.
TABLE 1 Asia Pacific Newborn Screening Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Newborn Screening Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Consumables Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Consumables Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Instrument Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Instrument Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Blood Test Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Blood Test Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Hearing Screening Test Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Hearing Screening Test Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Heart screening Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Heart screening Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Clinical Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Clinical Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Tandem Mass Spectrometry (TMS) Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Tandem Mass Spectrometry (TMS) Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Molecular Assays Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Molecular Assays Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Immunoassays & Enzymatic Assays Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Immunoassays & Enzymatic Assays Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Hearing Screen Technology Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Hearing Screen Technology Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Pulse Oximetry Screening Technology Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Pulse Oximetry Screening Technology Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 37 Asia Pacific Newborn Screening Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific Newborn Screening Market by Country, 2022 - 2028, USD Million
TABLE 39 China Newborn Screening Market, 2018 - 2021, USD Million
TABLE 40 China Newborn Screening Market, 2022 - 2028, USD Million
TABLE 41 China Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 42 China Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 43 China Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 44 China Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 45 China Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 46 China Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 47 China Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 48 China Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 49 Japan Newborn Screening Market, 2018 - 2021, USD Million
TABLE 50 Japan Newborn Screening Market, 2022 - 2028, USD Million
TABLE 51 Japan Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 52 Japan Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 53 Japan Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 54 Japan Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 55 Japan Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 56 Japan Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 57 Japan Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 58 Japan Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 59 India Newborn Screening Market, 2018 - 2021, USD Million
TABLE 60 India Newborn Screening Market, 2022 - 2028, USD Million
TABLE 61 India Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 62 India Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 63 India Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 64 India Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 65 India Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 66 India Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 67 India Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 68 India Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 69 South Korea Newborn Screening Market, 2018 - 2021, USD Million
TABLE 70 South Korea Newborn Screening Market, 2022 - 2028, USD Million
TABLE 71 South Korea Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 72 South Korea Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 73 South Korea Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 74 South Korea Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 75 South Korea Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 76 South Korea Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 77 South Korea Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 78 South Korea Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 79 Singapore Newborn Screening Market, 2018 - 2021, USD Million
TABLE 80 Singapore Newborn Screening Market, 2022 - 2028, USD Million
TABLE 81 Singapore Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 82 Singapore Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 83 Singapore Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 84 Singapore Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 85 Singapore Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 86 Singapore Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 87 Singapore Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 88 Singapore Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 89 Malaysia Newborn Screening Market, 2018 - 2021, USD Million
TABLE 90 Malaysia Newborn Screening Market, 2022 - 2028, USD Million
TABLE 91 Malaysia Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 92 Malaysia Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 93 Malaysia Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 94 Malaysia Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 95 Malaysia Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 96 Malaysia Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 97 Malaysia Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 98 Malaysia Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 99 Rest of Asia Pacific Newborn Screening Market, 2018 - 2021, USD Million
TABLE 100 Rest of Asia Pacific Newborn Screening Market, 2022 - 2028, USD Million
TABLE 101 Rest of Asia Pacific Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 102 Rest of Asia Pacific Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 103 Rest of Asia Pacific Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 104 Rest of Asia Pacific Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 105 Rest of Asia Pacific Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 106 Rest of Asia Pacific Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 107 Rest of Asia Pacific Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 108 Rest of Asia Pacific Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 109 Key Information – General Electric (GE) Co.
TABLE 110 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 111 Key Information – Bio-Rad Laboratories, Inc.
TABLE 112 Key Information – Natus Medical Incorporated
TABLE 113 key Information – Masimo Corporation
TABLE 114 Key Information – Waters Corporation
TABLE 115 key Information – PerkinElmer, Inc.
TABLE 116 Key Information – AB Sciex LLC
TABLE 117 Key Information – Medtronic PLC
TABLE 118 Key Information – Trivitron Healthcare Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: General electric (GE) Co.
FIG 3 Recent strategies and developments: Masimo Corporation
FIG 4 Swot analysis: Medtronic plc